Last reviewed · How we verify
NCT06202469: CRESPAQ10
Creatine and Ubiquinol for Sperm Quality
NA trial testing Supplement 1 in Oligospermia in 18 participants. Completed in 30 June 2024.
31 May 2024
Quick facts
| Lead sponsor | University of Novi Sad, Faculty of Sport and Physical Education |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 15 December 2023 |
| Primary completion | 31 May 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Serbia |
Drugs / interventions tested
- Supplement 1
- Supplement 2
- Placebo
Conditions studied
- Oligospermia — all drugs for Oligospermia →
- Sperm Count, Low — all drugs for Sperm Count, Low →
Sponsor
University of Novi Sad, Faculty of Sport and Physical Education
Who can join
Adults 18 to 35, male only, with Oligospermia or Sperm Count, Low. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled double-blind parallel-group interventional trial explores the impact of 8-week creatine supplementation, with or without ubiquinol, on sperm quality biomarkers in normospermic and oligospermic men. It aims to determine potential enhancements in sperm health to provide insights into male fertility and reproductive health improvement strategies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effects of 8-week creatine supplementation with and without ubiquinol on sperm quality biomarkers in normospermic and oligospermic men: A randomized controlled pilot trial.
Nedeljkovic D, Todorovic N, Javorac D, Baltic S, et al · · 2025 · cited 1× · PMID 41052075 · DOI 10.1177/02601060251385000
Verify or expand the search:
- PubMed search for NCT06202469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oligospermia
Currently open trials in the same condition.
- NCT07357701 — Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI) · recruiting
- NCT05842239 — Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia. · NA · recruiting
Other University of Novi Sad, Faculty of Sport and Physical Education trials
Trials by the same sponsor.
- NCT06859879 — A Combined Supplementation of Rosemary and Daylily for Enhancing Sleep Quality in Middle-Aged Adults · NA · completed
- NCT06968715 — Hydrogen-Rich Water and Metabolic Health in Adults: A 12-Week Randomized Trial · NA · completed
- NCT06788015 — Hydrogen-Infused Water for Endurance Performance, Body Hydration Biomarkers, and Health-Related Quality of Life · NA · completed
- NCT06660004 — Creatine HCl and Creatine Ethyl Ester Supplementation in Perimenopausal and Menopausal Women · NA · completed
- NCT06722326 — Hydrogen-rich Water and Appetite in Obesity · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06202469 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Novi Sad, Faculty of Sport and Physical Education
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06202469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing